Drug
Candonilimab
Candonilimab is a pharmaceutical drug with 4 clinical trials. Currently 2 active trials ongoing.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
2(50%)
Phase Distribution
Ph phase_2
4
100%
Phase Distribution
0
Early Stage
4
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
4(100.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
0.0%
0 of 1 finished
Non-Completion Rate
100.0%
1 ended early
Currently Active
2
trials recruiting
Total Trials
4
all time
Status Distribution
Active(2)
Terminated(1)
Other(1)
Detailed Status
Recruiting2
unknown1
Withdrawn1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
2
Success Rate
N/A
Most Advanced
Phase 2
Trials by Phase
Phase 24 (100.0%)
Trials by Status
unknown125%
withdrawn125%
recruiting250%
Recent Activity
2 active trials
Showing 4 of 4
recruitingphase_2
Efficacy and Safety of Cadonilimab Plus Anlotinib in Advanced STS That Failed the Previous First-line Standard Treatment
NCT05926700
recruitingphase_2
Cadonilimab With Chemotherapy in Treating Advanced Biliary Cancer
NCT05978609
withdrawnphase_2
Candonilimab Plus Bevacizumab for Patients With Advanced HCC Who Progressed on A+T
NCT05886257
unknownphase_2
Candonilimab Plus Bevacizumab for Patients With Advanced HCC Who Progressed on A+T
NCT05760599
Clinical Trials (4)
Showing 4 of 4 trials
NCT05926700Phase 2
Efficacy and Safety of Cadonilimab Plus Anlotinib in Advanced STS That Failed the Previous First-line Standard Treatment
NCT05978609Phase 2
Cadonilimab With Chemotherapy in Treating Advanced Biliary Cancer
NCT05886257Phase 2
Candonilimab Plus Bevacizumab for Patients With Advanced HCC Who Progressed on A+T
NCT05760599Phase 2
Candonilimab Plus Bevacizumab for Patients With Advanced HCC Who Progressed on A+T
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4